A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis

FEMS Immunology and Medical Microbiology

Volumn 36, Issue 3, 2003, Pages 187-192

  Chmiela, Magdalena ^a   Kowalewicz Kulbat, Magdalena ^a   Miszczak, Aneta ^a   Wisniewska, Monika ^a   Rechcinski, Tomasz ^b   Kolodziej, Katarzyna ^b   Kasprzak, Jaroslaw ^b   Wadstrom, Torkel ^c   Rudnicka, Wieslawa ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Chlamydia spp.; Helicobacter pylori

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CAGA PROTEIN; GLYCINE; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ATHEROSCLEROSIS; CHLAMYDIA; CHLAMYDIASIS; CONFERENCE PAPER; CONTROLLED STUDY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM BOVIS; PREVALENCE; PRIORITY JOURNAL;

EID: 0038399975     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00030-0     Document Type: Conference Paper

References (25)

1. Watanabe T., Haraoka S., Shimaoka T. Inflammatory and immunological nature of atherosclerosis. Int. J. Cardiol. 54:(Suppl.):1996;S25-S34.
2. Kiechl S., Egger G., Mayr M., Wiedermann Ch.J., Bonora E., Oberhollenzer F., Muggeo M., Xu Q., Wich G., Poewe W., Willeit J. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation. 103:2001;1064-1070.
3. Burian K., Kis Z., Virok D., Endresz V., Prohaszka Z., Duba J., Berencsi K., Boda K., Howath L., Romics L., Fust G., Gonczol E. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation. 103:2001;1503-1508.
4. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., Wich G. Endothelial cytotoxicity mediated by serum antibodies to heat shock protein of Escherichia coli and Chlamydia pneumoniae; immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 99:1999;1560-1566.
5. Yokata K., Hirai Y., Hoque H., Hayashi S., Isogai H., Sugiyama T., Nagamachi E., Tsukada Y., Fuji N., Oguma K. Heat shock protein produced by Helicobacter pylori. Microbiol. Immunol. 38:1994;403-405.
6. Rechcinski T., Chmiela M., Malecka-Panas E., Planeta-Malecka I., Rudnicka W. Serologic indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors. Microbiol. Immunol. 41:1997;387-393.
7. Kaca W., Cedzynski M., Cieslikowski T., Chmiela M., Czkwianianc E., Planeta-Malecka I., Rudnicka W. The differentiation of Helicobacter pylori strains based on cell surface antigens and PCR. Akita J. Med. 24:1997;117-121.
8. Raulston J.E. Chlamydial envelope components and pathogen-host cell interaction. Mol. Microbiol. 15:1995;607-616.
9. Fischer S.F., Schwartz C., Hacher G. Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect. Immun. 69:2001;7121-7129.
10. Gasbarini A., Franceschi F., Cammarota G., Pola P., Gasbarini G. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital. J. Gastroenterol. Hepatol. 30:1998;115-118.
11. Gunn M., Stephens J.C., Tomson J.R., Rathbone B.J., Samani N.J. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart. 84:2000;267-271.
12. Niemela S., Karttunen T., Korhonen T., Laara E., Karttunen R., Ikaheimo M., Kesaniemi Y.A. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 75:1996;573-575.
13. Forsak B., Yildiriv A., Akoyon Y., Pinar A., Oc M., Boke E., Kes S., Tokgozoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atheroscterotic plaques by PCR. J. Clin. Microbiol. 12:2000;4408-4411.
14. Meijer A., Roholl P.J.M., Gielis-Propers S.K., Ossewaarde J.M. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerosis lesions. J. Clin. Pathol. 53:2000;911-916.
15. Ossewaarde J.M., Feskens E.J.M., de Vries A., Vallinga C.E., Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol. Infect. 120:1998;93-99.
16. Nobel M., Torrente A., Peter O., Genne D. No serological evidence of association between Chlamydia pneumoniae infection and acute coronary heart disease. Scand. J. Infect. Dis. 31:1999;261-264.
17. Schumacher A., Lerkerod A.B., Seljeflot I., Sommervoll L., Holme I., Offerstad J.E., Arnesen H. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J. Clin. Microbiol. 39:2001;1859-1864.
18. Kovanen P.T., Mantari M., Palosuo T., Maninen V., Aho K. Prediction of myocardial infarction in dyslipidemic man by elevated levels of immunoglobulin classes A, E and G, but not M. Arch. Intern. Med. 158:1998;1434-1439.
19. Peek R.M., Miller G.G., Tham K.T. Hightened inflammatory response and cytokine expression in vivo to CagA+ H. pylori strains. Lab. Invest. 73:1995;760-770.
20. Koenig W., Rothenbacher D., Hoffmeister A., Miller M., Bode G., Adler G., Hombach V., Marz W., Pepy M.B., Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease. Lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation. 100:1999;2326-2331.
21. Mendall M., Goggin P.M., Mollneaux N., Levy J., Toosy T., Schackan D., Cam A.J., Nortfield T.C. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 71:1994;437-439.
22. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Rippin G., Hafner G., Pfeifer U., Meyer J. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke. 31:2000;2127-2133.
23. Haralambiera I., Jankov J., Petrov D., Jvanova R., Kamarinchev B., Mitov J. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli 0119 and Salmonella newington: implications for diagnosis. Diagn. Microbiol. Infect. Dis. 41:2001;99-106.
24. Zhu J., Quyyumi A., Rott D., Csako G., Hongsheng W., Halcox J., Epstein S. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease. Evidence for an autoimmune components of atherosclerosis. Circulation. 103:2001;1071-1075.
25. Rudnicka W., Czkwianinac E., Planeta-Malecka I., Jurkiewicz M., Wisniewska M., Cieslikowski T., Rozalska B., Wadstrom T., Chmiela M. A potential double role of anti-Lewis X antibodies in Helicobacter pylori associated gastroduodenal disease. FEMS Immunol. Microbiol. 30:2001;121-125.